Trials / Conditions / Meropenem
Meropenem
6 registered clinical trials studyying Meropenem — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children NCT06929702 | University Hospital, Ghent | Phase 4 |
| Completed | Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Pat NCT07113574 | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | Phase 2 / Phase 3 |
| Completed | The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitori NCT03790631 | University of Geneva, Switzerland | — |
| Recruiting | Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO) NCT06426836 | University Hospital, Ghent | N/A |
| Completed | Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Auto NCT07113587 | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | Phase 2 / Phase 3 |
| Recruiting | Antibiotic Dosing in Pediatric Intensive Care NCT02456974 | University Hospital, Ghent | — |